Fate Therapeutics (FATE) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Fate Therapeutics (FATE) over the last 12 years, with Q4 2024 value amounting to $35.1 million.
- Fate Therapeutics' Accumulated Depreciation & Amortization fell 2622.52% to $35.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $35.1 million, marking a year-over-year decrease of 2622.52%. This contributed to the annual value of $35.1 million for FY2024, which is 2622.52% down from last year.
- Latest data reveals that Fate Therapeutics reported Accumulated Depreciation & Amortization of $35.1 million as of Q4 2024, which was down 2622.52% from $47.6 million recorded in Q4 2023.
- In the past 5 years, Fate Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $47.6 million in Q4 2023 and a low of $11.1 million during Q4 2020
- In the last 5 years, Fate Therapeutics' Accumulated Depreciation & Amortization had a median value of $30.4 million in 2022 and averaged $28.2 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 7930.95% in 2022, then crashed by 2622.52% in 2024.
- Quarter analysis of 5 years shows Fate Therapeutics' Accumulated Depreciation & Amortization stood at $11.1 million in 2020, then skyrocketed by 52.73% to $16.9 million in 2021, then skyrocketed by 79.31% to $30.4 million in 2022, then skyrocketed by 56.75% to $47.6 million in 2023, then dropped by 26.23% to $35.1 million in 2024.
- Its last three reported values are $35.1 million in Q4 2024, $47.6 million for Q4 2023, and $30.4 million during Q4 2022.